跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/EUCTR2007-004021-19-FI
EUCTR2007-004021-19-FI进行中（未招募）1 期

OPHO ALL-2008 Pilot Study on consolidation therapy for children and young adults with acute lymphoblastic leukaemia

Rigshospitalet0 个研究点目标入组 75 人开始时间: 2008年5月5日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
相关药物

试验速览

阶段
1 期
状态
进行中（未招募）
入组人数
75
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •B-lineage ALL with a white blood cell count of < 100 x 10E9/l and age at diagnosis 1.0-17.9 yrs, no t(9;22), no hypodiploidy, no 11q23(MLL)-aberrations, no t(1;19), no TPMT deficiency, no known intolerance to MD-MTX and/or oral 6MP and a written consent obtained for participation.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) no
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •If not one of the above is met

研究者

相似试验

进行中（未招募）
不适用
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008p
EUCTR2007-004021-19-SERigshospitalet75
进行中（未招募）
1 期
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008pAcute lymphoblastic leukemia in children 1.0-18 years of ageMedDRA version: 9.1Level: LLTClassification code 10066109Term: Precursor B-lymphoblastic leukemia acute
EUCTR2007-004021-19-DKRigshospitalet75
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395
EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
招募中
2 期
Induction of remission and consolidation therapy using ATRA and ATO for acute promyelocytic leukemia - JSCT APL2021Acute promyelocytic leukemia
JPRN-jRCTs071210035Takase Ken90
尚未招募
1 期
A study in blood cancer patients to check the effect of two oral drugs in maintaining the status of the patient disease free. The medicines that will be given are azacytidine and pomalidomide.
CTRI/2023/09/057552Tata Memorial Centre